Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist

Details for Australian Patent Application No. 2002347509 (hide)

Owner Pfizer Inc.

Inventors Smith, Julian, Duncan; Silk, Terence, Vernon

Agent Spruson & Ferguson

Pub. Number AU-B-2002347509

PCT Number PCT/IB02/04979

PCT Pub. Number WO2003/048180

Priority 0129273.9 06.12.01 GB

Filing date 27 November 2002

Wipo publication date 17 June 2003

Acceptance publication date 18 September 2008

International Classifications

C07H 19/167 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7076 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 15/12 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 0129273.9 06.12.01 GB

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002347509

18 September 2008 Application Accepted

  Published as AU-B-2002347509

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002347510-MULTIMEDIA STORAGE AND CONTROL SYSTEM

2002347508-NON-HALOGENATED HYDROXYALKYL-SUBSTITUTED PHENOL COMPOUNDS, ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME